| |
| |
|
| Insider
Information: |
Squinto Stephen P |
| Relationship: |
Director, 10% Owner |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
245,634 |
|
|
Indirect Shares
|
6,290,493 |
|
|
| Direct
Value |
$19,885,926 |
|
|
|
Indirect Value
|
$19,013,945 |
|
|
| Total
Shares |
6,536,127 |
|
|
| Total
Value |
$38,899,871 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Global Ops.... |
2014-10-27 |
106,508 |
2013-10-28 |
104,186 |
Premium* |
|
|
Audentes Therapeutics, Inc. |
BOLD |
Director |
2016-07-19 |
7,474 |
|
0 |
Premium* |
|
|
Springworks Therapeutics, Inc. |
SWTX |
Director, 10% Owner |
2022-05-19 |
131,652 |
2022-05-19 |
6,186,307 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,818 |
131,652 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,106 |
126,834 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2021-04-28 |
4 |
AS |
$76.20 |
$1,465,437 |
D/D |
(19,231) |
125,728 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2021-04-27 |
4 |
AS |
$75.05 |
$15,085 |
D/D |
(201) |
144,959 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2021-04-15 |
4 |
AS |
$75.01 |
$79,291 |
D/D |
(1,057) |
145,160 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2021-04-14 |
4 |
AS |
$75.08 |
$38,365 |
D/D |
(511) |
146,217 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2019-09-17 |
4 |
B |
$18.00 |
$4,950,000 |
I/I |
275,000 |
7,406,307 |
2.25 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2019-09-17 |
4 |
A |
$0.00 |
$0 |
I/I |
7,131,307 |
7,131,307 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2019-09-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
146,728 |
|
- |
|
| BOLD |
Audentes Therapeutics, In... |
Director |
– • – |
2016-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,474 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-10-27 |
4 |
AS |
$188.36 |
$1,114,532 |
D/D |
(5,910) |
106,508 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-10-27 |
4 |
OE |
$42.66 |
$348,140 |
D/D |
5,550 |
112,418 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-10-03 |
4 |
OE |
$42.66 |
$427,666 |
D/D |
10,025 |
116,893 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-10-03 |
4 |
AS |
$169.95 |
$1,728,374 |
D/D |
(10,025) |
106,868 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-09-24 |
4 |
S |
$159.50 |
$12,122 |
D/D |
(76) |
106,868 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-08-04 |
4 |
S |
$157.42 |
$261,632 |
D/D |
(1,662) |
106,944 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
108,606 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-10 |
4 |
S |
$167.31 |
$273,552 |
D/D |
(1,635) |
101,308 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-07 |
4 |
S |
$155.55 |
$252,030 |
D/D |
(1,620) |
102,943 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,745 |
104,563 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-06 |
4 |
S |
$155.11 |
$589,418 |
D/D |
(3,800) |
94,818 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-06 |
4 |
OE |
$93.83 |
$356,554 |
D/D |
3,800 |
98,618 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-04 |
4 |
S |
$153.63 |
$5,603,781 |
D/D |
(36,137) |
94,818 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-04 |
4 |
OE |
$22.90 |
$1,656,469 |
D/D |
28,739 |
124,455 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-03 |
4 |
S |
$157.14 |
$133,883 |
D/D |
(852) |
102,216 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
